Showing results (1491-1500 of 2,679) with videos related to

Sort By:
Pageof 268
Neurotoxicology|August 22, 2018
Potentiation of antiseizure and neuroprotective efficacy of standard nerve agent treatment by addition of tariquidarGideon F Meerhoff, Stefanie M Vester, Peter Hesseling, et al.
The New Phytologist|November 21, 2009
The importance of wood traits and hydraulic conductance for the performance and life history strategies of 42 rainforest tree speciesLourens Poorter, Imole McDonald, Alfredo Alarcón, et al.
JAMA Oncology|January 4, 2019
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysisChristopher J D Wallis, Mohit Butaney, Raj Satkunasivam, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 31, 2006
Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathyBrenda Gerull, John Atherton, Anke Geupel, et al.
Acta Psychiatrica Scandinavica|August 18, 2010
Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosisE Velthorst, D H Nieman, R M C Klaassen, et al.
Nature Medicine|March 12, 2013
Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapyFeng Li, Jie Lu, Jie Cheng, et al.
Psychiatry Research|February 26, 2013
Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosisJudith Rietdijk, Helga K Ising, Sara Dragt, et al.
Tijdschrift Voor Psychiatrie|March 22, 2019
[Improving the quality of supervision of residents: an evaluation of supervisors using feedback by residents]C R M G Fluit, T P F M Klaassen, L Sander, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with plantinumA du Bois, H J Lück, K Buser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II studyU Klaassen, H Wilke, A Harstrick, et al.
Pageof 268